Influence of apolipoproteinCII concentrations on HDL subclass distribution

Journal of Atherosclerosis and Thrombosis

Volumn 16, Issue 5, 2009, Pages 611-620

  Li, Tian ^a,b   Yanhua, Xu ^c   Mingde, Fu ^a,b   Lianqun, Jia ^a   Yuye, Yang ^a,b  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

^c Chengdu Hoist Biotechnology Co LTD   (China)

Author keywords

2 dimensional gel electrophoresis immunodetection; ApolipoproteinA I; ApolipoproteinCII; HDL subclass distribution

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN C2; APOLIPOPROTEIN C3; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN 2; HIGH DENSITY LIPOPROTEIN 2A; HIGH DENSITY LIPOPROTEIN 2B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; FEMALE; HUMAN; HUMAN EXPERIMENT; IMMUNODETECTION; LIPOPROTEIN BLOOD LEVEL; MALE; PARTICLE SIZE; TRIACYLGLYCEROL BLOOD LEVEL; TWO DIMENSIONAL GEL ELECTROPHORESIS;

EID: 73249118679     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.1156     Document Type: Article

References (42)

1. Miller GJ, Miller NE: Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease. Lancet, 1975; 1: 16-19
2. Rhoads GG, Gulbrandsen GL, Kagan A: Serum lipoproteins and coronary heart disease in a population study of Hawaii Japanese men. N Engl J Med, 1976; 294: 293-298
3. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR: High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study Am J Med, 1977; 62: 707-714
4. Tyroler HA: Epidemiology of plasma high-density lipoprotein cholesterol levels. Circulation, 1980; 62(Suppl.IV): IV1-IV3
5. Patsch JR, Karlin JB, Scott LW, Smith LC, Gotto AM Jr: Inverse relationship between blood levels of high density lipoproteins subfraction 2 and magnitude of postprandial lipemia. Proc Natl Acad Sci USA, 1983; 80: 1449-1453
6. Anderson DW, Nichols AV, Pan SS, Lindgren FT: High density lipoprotein distribution. Resolution and determination of three major components in a normal population sample. Atherosclerosis, 1978; 29: 161-179
7. Rothblat GH, Bmberger M, Phillips MC: Reverse cholesterol transport. Methods Enzymol, 1986; 129: 628-644
8. Von Eckardstein A., Huang Y, Assmann G: Physiological role and clinical relevance of high-density lipoprotein subclasses. Curr Opin Lipidol, 1994; 5: 404-416
9. Mowri HO, Patsch W, Smith LC, Gotto AM Jr, Patsch JR: Different reactivities of high-density lipoprotein2 subfractions with hepatic lipase. J Lipid Res, 1992; 33: 1269-1279
10. Miida T, Kawano M, Fielding CJ, Fielding PE: Regulation of the concentration of pre beta high-density lipoprotein in normal plasma by cell membranes and lecithin-cholesterol acyltransferase activity. Biochemistry, 1992; 31: 11112-11117
11. Yang YY, Yan B, Fu M, Xu Y, Tian Y: Relationship between plasma lipid concentrations and HDL subclasses. Clin Chim Acta, 2005; 354: 49-58
12. Gou LT, Fu M, Xu Y, Tian Y, Yan B, Yang L: Alterations of high-density lipoprotein subclasses in endogenous hypertriglyceridemia. Am Heart J, 2005; 150: 1039-1045
13. Jia L, Long S, Fu M, Yan B, Tian Y, Xu Y, Gou L: Relationship between total cholesterol/high-density lipoprotein cholesterol ratio, triglyceride/high-density lipoprotein cholesterol ratio, and high-density lipoprotein subclasses. Metabolism, 2006; 55: 1141-1148
14. Jia L, Fu M, Tian Y, Xu Y, Gou L, Tian H, Tian L: Alterations of high-density lipoprotein subclasses in hypercholesterolemia and combined hyperlipidemia. Int J Cardiol, 2007; 120: 331-337
15. Tian L, Fu M, Jia L, Xu Y, Long S, Tian H, Tian Y: Relationship between apolipoprotein concentrations and HDL subclasses distribution. Lipids, 2007; 42: 419-426
16. Tian L, Wu X, Fu M, Qin Y, Xu Y, Jia L: Relationship between plasma apolipoproteinB concentrations, apolipoproteinB/apolipoproteinA-I and HDL subclasses distribution. Clin Chim Acta, 2008; 388: 148-155
17. Warnick GR, Nguyen T, Albers AA: Comparison of improved precipitation methods for quantification of high-density lipoprotein cholesterol. Clin Chem, 1985; 31: 217-222
18. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem, 1972; 18: 499-502
19. Labeur C, Shepherd J, Rosseneu M: Immunological assays of apolipoproteins in plasma: methods and instrumentation. Clin Chem, 1990; 36: 591-597
20. Liu BW: Immunoassay of human plasma apolipoproteins and clinical applications. In: Lipoproteins and Atherosclerosis. Ed by Wang KQ, pp359-368, Beijing: People's Health Press,1995
21. Wu XW, Fu MD, Liu BW: Study on the immunodetection method of HDL subclasses in human plasma. Chin J Areterioscler, 1999; 7: 253-255
22. Havel RJ, Kane JP, Kashyap ML: Interchange of apolipoproteins between chylomicrons and high density lipoproteins during alimentary lipemia in man. J Clin Invest, 1973; 52: 32-38
23. Quarfordt SH, Frank A, Shames DM, Berman M, Steinberg D: Very low density lipoprotein triglyceride transport in type IV hyperlipoproteinemia and the effects of carbohydrate-rich diets. J Clin Invest, 1970; 49: 2281-2297
24. Breckenridge WC, Little JA, Steiner G, Chow A, Poapst M: Hypertriglyceridemia associated with a deficiency of apolipoprotein C-II. New Engl J Med, 1978; 298: 1265-1273
25. Shachter NS, Hayek T, Leff T, Smith JD, Rosenberg DW, Walsh A, Ramakrishnan R, Goldberg IJ, Ginsberg HN, Breslow JL: Overexpression of apolipoprotein C?? causes hypertriglyceridemia in transgenic mice. J Clin Invest, 1994; 93: 1683-1690
26. Schonfeld G, George PK, Miller J, Reilly P, Witztum J: Apolipoprotein CII and CIII levels in hyperlipoproteinemia. Metabolism, 1979; 28: 1001-1010
27. Kashyap ML, Srivastava LS, Chen CY, Perisutti CG, Campbell M, Lutmer RF, Glueck CJ: Radioimmunoassay of human apolipoprotein CII. A study in normal and hypertriglyceridemic subjects. J Clin Invest, 1977; 60: 171-180
28. Falko JM, Schonfeld J, Witztum JL, Kolar JB, Salmon P: Effects of short-term high carbohydrate, fat-free diet on plasma levels of Apo CII and Apo CIII and on the Apo C subspecies in human plasma lipoproteins. Metabolism, 1980; 29: 654-661
29. Witztum JL, Schonfeld G: Carbohydrate diet-induced changes in very low density lipoprotein composition and structure. Diabetes, 1978; 27: 1215-1229
30. Patsch JR, Gotto AM Jr, Olivercrona T, Eisenberg S: Formation of high density lipoprotein2-like particles during lipolysis of very low density lipoproteins in vitro. Proc Natl Acad Sci USA, 1978; 75: 4519-4523
31. Taskinen MR, Glueck CJ, Kashyap ML, Srivastava LS, Hynd BA, Perisutti G, Robinson K, Kinnunen PJ, Kuusi T: Post-heparin plasma lipoprotein and hepatic lipases relationships to high density lipoprotein cholesterol and to apolipoprotein C?? in Familial hyperalphalipoproteinemic and in normal subjects. Atherosclerosis, 1980; 37: 247-256
32. Havel RJ, Fielding CJ, Olivecrona T, Shore VG, Fielding PE, Egelrud T: Cofactor activity of protein components of human very low density lipoproteins in the hydrolysis of triglycerides by lipoprotein lipase from different sources. Biochemistry, 1973; 12: 1828-1833
33. Tornvall P, Olivecrona G, Karpe F, Hamsten A, Olivecrona T: Lipoprotein Lipase mass and activity in plasma and their increase after heparin are separate parameters with different relations to plasma lipoproteins. Arterioscler Thromb Vasc Biol, 1995; 15: 1086-1093
34. Saidi Y, Sich D, Camproux A, Egloff M, Federspiel MC, Gautier V, Raisonnier A, Turpin G, Beucler I: Interrelationships between postprandial lipoprotein B: CIII particle changes and high-density lipoprotein subpopulation profiles in mixed hyperlipoproteinemia. Metabolism, 1999; 48: 60-67
35. Lee M, Kim JQ, Kim J, Oh H, Park M: Studies on the plasma lipid profiles, and LCAT and CETP activities according to hyperlipoproteinemia phenotypes (HLP). Atherosclerosis, 2001; 159: 381-389
36. Barrans A, Collet X, Barbaras R, Jaspard R, Manent J, Vieu C, Chap H, Perret B: Hepatic lipase induces the formation of pre-beta1-high density lipoprotein (HDL) from triacylglycerol-rich HDL2. A study comparing liver perfusion to in vitro incubation with lipases. J Biol Chem, 1994; 269: 11572-11577
37. Miida T,Yamaguchi T, Tsuda T, Okada M: High prebeta1-HDL levels in hypercholesterolemia are maintained by probucol but reduced by a low-cholesterol diet. Atherosclerosis, 1998; 138: 129-134
38. Miyazaki O, Fukamachi I, Mori A, Hashimoto H, Kawashiri M, Nohara A, Noguchi T, Inazu A, Yamagishi M, Mabuchi H, Kobayashi J: Formation of prebeta1-HDL during lipolysis of triglyceride-rich lipoprotein. Biochem Bioph Res Commun, 2009; 379: 55-59
39. Sasaki N, Holdworth G, Barnhart RL, Srivastava LS, Glueck CS, Kashyap ML, Jackson RL: Effect of a high carbohydrate diet on the content of apolipoproteins CII, CIII and E in human plasma high density lipoprotein subfractions. Atherosclerosis, 1983; 46: 341-352
40. Le NA, Gibson JC, Ginsberg HN: Independent regulation of plasma apolipoprotein CII and CIII concentrations in very low density and high density lipoproteins: implications for the regulation of the catabolism of these lipoproteins. J Lipid Res, 1988; 29: 669-677
41. Alaupovic P: David Rubenstein Memorial Lecture: the biochemical and clinical significance of the interrelationship between very low density and high density lipoproteins. Can J Biochem, 1981; 59: 565-579
42. Jonas A, Kezdy KE, Wald JH: Defined apolipoprotein A-I conformations in reconstituted high density lipoprotein discs. J Biol Chem, 1989; 264: 4818-4824